Overview
IgG4-related disease (also called IgG4-RD) is an uncommon condition in which the immune system causes inflammation and scarring (fibrosis) in one or more organs of the body. The name comes from a specific type of antibody called immunoglobulin G4 (IgG4), which is often found at high levels in the blood and in affected tissues. This disease can affect almost any organ, but the most commonly involved areas include the pancreas, salivary glands, tear glands (lacrimal glands), bile ducts, kidneys, lungs, and the tissue around the aorta (the body's largest blood vessel). When the pancreas is affected, it can be mistaken for pancreatic cancer. When salivary or tear glands swell, it may look like Sjögren syndrome or lymphoma. Symptoms depend on which organs are involved. Common signs include painless swelling of glands, abdominal pain, jaundice (yellowing of the skin), kidney problems, or shortness of breath. Many patients have multiple organs affected at the same time or over the course of the disease. The condition tends to develop slowly, and patients may not notice symptoms until significant damage has occurred. IgG4-related disease is not a cancer and is not an infection. It is considered an immune-mediated condition, meaning the body's own immune system mistakenly attacks healthy tissues. Treatment typically involves medications that suppress the overactive immune response. Corticosteroids like prednisone are the first-line treatment and are very effective in most patients. For patients who relapse or cannot tolerate steroids, other immunosuppressive drugs or the targeted biologic rituximab may be used. Early diagnosis and treatment are important to prevent permanent organ damage from fibrosis.
Key symptoms:
Painless swelling of salivary glands in the cheeks or under the jawSwelling of tear glands causing puffy eyelidsYellowing of the skin and eyes (jaundice)Abdominal or back painUnexplained weight lossFatigue and general tirednessKidney problems or decreased kidney functionShortness of breath or coughDry eyes or dry mouthEnlarged lymph nodesThyroid gland enlargementNumbness or tingling from nerve involvementSkin rashes or nodulesDifficulty swallowingSwelling around the aorta or other blood vessels
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
10 eventsAmgen — PHASE2
Acepodia Biotech, Inc. — PHASE1, PHASE2
Changhai Hospital — EARLY_PHASE1
Stanford University — PHASE2
Sanofi — PHASE3
Chinese PLA General Hospital — PHASE2
Peking Union Medical College Hospital — PHASE2, PHASE3
Luo Yaping — NA
IRCCS San Raffaele
Peking University Third Hospital
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableUplizna
indicated for the treatment of Immunoglobulin G4-related disease (IgG4-RD) in adult patients
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
2 resourcesLeustatin Injection
R. W. Johnson Pharmaceutical Research Institute
Leustatin Injection — Contact R. W. Johnson Pharmaceutical Research Institute
Travel Grants
No travel grants are currently matched to IgG4-related disease.
Community
No community posts yet. Be the first to share your experience with IgG4-related disease.
Start the conversation →Latest news about IgG4-related disease
Disease timeline:
New recruiting trial: Short-term Glucocorticoid Combined with MMF for IgG4-RD
A new clinical trial is recruiting patients for IgG4-related disease
New recruiting trial: A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
A new clinical trial is recruiting patients for IgG4-related disease
New recruiting trial: Study to Assess Safety, Efficacy and Persistence of ACE1831, in Subjects With IgG4-Related Disease
A new clinical trial is recruiting patients for IgG4-related disease
New recruiting trial: Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease
A new clinical trial is recruiting patients for IgG4-related disease
New recruiting trial: Treatment Strategies for IgG4-RD Patients With Internal Organ Involvement
A new clinical trial is recruiting patients for IgG4-related disease
New recruiting trial: A Prospective Cohort Study of IgG4RD in China
A new clinical trial is recruiting patients for IgG4-related disease
New recruiting trial: Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease
A new clinical trial is recruiting patients for IgG4-related disease
New recruiting trial: A Study of Efgartigimod in Patients With IgG4-Related Disease
A new clinical trial is recruiting patients for IgG4-related disease
New recruiting trial: Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease
A new clinical trial is recruiting patients for IgG4-related disease
New recruiting trial: A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease
A new clinical trial is recruiting patients for IgG4-related disease
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which of my organs are affected by IgG4-related disease, and how much damage has already occurred?,What is my treatment plan, and how long will I need to take steroids?,What are the side effects of my medications, and how can we minimize them?,How often will I need blood tests and imaging to monitor my condition?,What are the signs of a relapse that I should watch for?,Are there clinical trials or newer treatments available for my condition?,Should I see additional specialists based on which organs are involved?
Common questions about IgG4-related disease
What is IgG4-related disease?
IgG4-related disease (also called IgG4-RD) is an uncommon condition in which the immune system causes inflammation and scarring (fibrosis) in one or more organs of the body. The name comes from a specific type of antibody called immunoglobulin G4 (IgG4), which is often found at high levels in the blood and in affected tissues. This disease can affect almost any organ, but the most commonly involved areas include the pancreas, salivary glands, tear glands (lacrimal glands), bile ducts, kidneys, lungs, and the tissue around the aorta (the body's largest blood vessel). When the pancreas is affect
How is IgG4-related disease inherited?
IgG4-related disease follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does IgG4-related disease typically begin?
Typical onset of IgG4-related disease is adult. Age of onset can vary across affected individuals.
Are there clinical trials for IgG4-related disease?
Yes — 16 recruiting clinical trials are currently listed for IgG4-related disease on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat IgG4-related disease?
25 specialists and care centers treating IgG4-related disease are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.
What treatment and support options exist for IgG4-related disease?
2 patient support programs are currently tracked on UniteRare for IgG4-related disease. See the treatments and support programs sections for copay assistance, eligibility, and contact details.